Keyphrases
5-fluorouracil (5-FU)
10%
Best Supportive Care
40%
Chemotherapy
100%
Chemotherapy Agents
10%
Chemotherapy Regimen
10%
Chemotherapy Treatment
10%
Cisplatin
10%
Clinical Trials
10%
Cochrane
20%
Cochrane Central Register of Controlled Trials
10%
Cochrane Library
10%
Conference Proceedings
10%
Digestive Disease Week
10%
Disease Groups
10%
Embase
10%
Esophageal Cancer
10%
Esophageal Squamous Cell Carcinoma
100%
Extracted Data
10%
Gastroenterology
20%
Gastroesophageal Junction
100%
Gut Diseases
10%
Issue 1
10%
Material Selection
10%
MEDLINE
10%
Metastatic Carcinoma
100%
Metastatic Disease
10%
Metastatic Esophageal Cancer
20%
Metastatic Esophageal Carcinoma
20%
Paclitaxel
10%
Palliative Treatment
10%
Pancreatic Diseases
10%
Patient Demographics
10%
Phase II Trial
10%
Pooled Analysis
10%
Quality of Life
10%
Quality of Life Assessment
10%
Quality of Life Improvement
10%
Randomized Controlled Trial
10%
Response Rate
10%
Search Strategy
10%
Selection Criteria
10%
Survival Benefit
10%
Treatment Modalities
10%
Trial Quality
10%
Tumor Control
10%
Upper Gastrointestinal Symptoms
10%
Nursing and Health Professions
Cancer Control
33%
Cisplatin
33%
Cochrane Library
66%
Enteropathy
33%
Esophagus Cancer
100%
Esophagus Carcinoma
66%
Fluorouracil
33%
Gastrointestinal Disease
66%
Metastasis
100%
Paclitaxel
33%
Palliative Therapy
33%
Pancreas Disease
33%
Patient Population
33%
Quality of Life
66%
Quality of Life Measure
33%
Medicine and Dentistry
Chemotherapy
100%
Chemotherapy Agent
9%
Chemotherapy Regimens
9%
Cisplatin
9%
Clinical Trial
9%
Enteropathy
9%
Esophageal Cancer
27%
Esophagus
100%
Esophagus Carcinoma
18%
Fluorouracil
9%
Gastroenterology
18%
Gastroesophageal Junction
100%
Gastrointestinal Disease
18%
Group Trial
9%
Metastatic Carcinoma
100%
Neoplasm
9%
Paclitaxel
9%
Pancreas Disease
9%
Patient Population
9%
Pooled Analysis
9%
Quality of Life
18%
Quality of Life Measure
9%
Randomized Controlled Trial
36%
Supportive Care
36%
Symptomatic Treatment
9%
Pharmacology, Toxicology and Pharmaceutical Science